Skip To Content
Search
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Type
All
AllStoriesVideoAudioGraphicsBusinessweek
Sort
By Newest
By NewestBy RelevanceBy Oldest
Time
Any Time
Any TimeLast 24 HoursPast WeekPast Month

Showing results for "Vaxart"

relates to Vaccine Makers Shake Off Slump Amid Growth Stock Relief Rally
markets
Vaccine Makers Shake Off Slump Amid Growth Stock Relief Rally
By Cristin Flanagan and Breanna Bradham
May 4, 2022
relates to Next Wave of Covid Vaccines Is on the Way
opinion
Next Wave of Covid Vaccines Is on the Way
By Max Nisen
New shots on the way from biotechnology startups and pharmaceutical giants will greatly aid the global pandemic fight. Here are four standouts.
May 20, 2021
relates to Yellen Concern About GameStop (GME) Trading Is Misplaced
opinion
Yellen Concern About GameStop (GME) Trading Is Misplaced
By Nir Kaissar
If policy makers want to protect investors and markets, they should help unsophisticated investors get savvier rather than put gates around all retail investors.
February 5, 2021
relates to Biotech Surpasses Gamestop as Year’s Best-Performing Retail Pick
markets
Biotech Surpasses Gamestop as Year’s Best-Performing Retail Pick
By Cristin Flanagan
Biotech mania has overtaken internet chat rooms, pushing aside recent retail trading stars GameStop Corp. and Express Inc.
February 5, 2021
relates to ‘Meme Stocks’ Rally Again With Penny Plays Leading the Way
markets
‘Meme Stocks’ Rally Again With Penny Plays Leading the Way
By Cristin Flanagan
Stocks recently targeted by retail investors soared again Wednesday as millions of shares changed hands. Penny stocks with a low amount of tradeable shares led the charge.
February 3, 2021
relates to Day Traders Put Stamp on Market With Unprecedented Stock Frenzy
markets
Day Traders Put Stamp on Market With Unprecedented Stock Frenzy
By Gearoid Reidy, Ishika Mookerjee, Sarah Ponczek, and Jan-Patrick Barnert
Look at a screen at almost any point in 2020, and chances are you saw something like this: A company that nobody had ever heard of 12 months ago was in the process of trading 20 million shares in a day.
December 31, 2020
relates to Personal Finance: Year-End Portfolio Tweaks for an Unusual Year
opinion
Personal Finance: Year-End Portfolio Tweaks for an Unusual Year
By Barry L Ritholtz
What not to do with your investments and taxes is just as important as what to do.
December 21, 2020
relates to Vaxart’s 2,000% Rally on Vaccine Pill Leaves Bears on Edge
markets
Vaxart’s 2,000% Rally on Vaccine Pill Leaves Bears on Edge
By Cristin Flanagan
Vaxart Inc.’s more than 2,000% rally this year on the promise of an oral Covid-19 vaccine has left the bears betting against it in rough waters. And time will tell if short sellers get a reprieve with clinical data due next month on how well Vaxart’s pill works.
December 11, 2020
relates to Covid-Tied Biotechs Unwind Gains After Pfizer Vaccine Data
markets
Covid-Tied Biotechs Unwind Gains After Pfizer Vaccine Data
By Cristin Flanagan
Biotech companies that are chasing treatments and vaccines for Covid-19 tumbled Monday after positive news about Pfizer Inc.’s inoculation.
November 9, 2020
relates to New York Spikes Again; WHO Faults U.S. Response: Virus Update
business
New York Spikes Again; WHO Faults U.S. Response: Virus Update
By Ian Fisher
October 2, 2020